Share:
Peer-Reviewed Publication
Open Forum Infect Dis2022;9(9):ofac415.September 1, 2022Journal Article

From Start to Finish: Examining Factors Associated With Higher Likelihood of Publication Among Abstracts Presented at an International Infectious Diseases Scientific Meeting.

Asia J Johnson1, Christopher M Bland2, Chengwen Teng3, Lily Zheng4, J Colin Hungerpiller3, Morgan Easterling5, Sarah Arnold3, Madeline Dean3, Carrington Royals6, P Brandon Bookstaver3
1Department of Pharmacy, Baylor University Medical Center, Dallas, Texas, USA.
2Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Savannah, Georgia, USA.
3Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, South Carolina, USA.
4Department of Pharmacy, University of Florida Health Shands Hospital, Gainesville, Florida, USA.
5Department of Pharmacy, Le Bonheur Children's Hospital and University of Tennessee Health Science Center, Memphis, Tennessee, USA.
6Department of Pharmacy, Tandem Health SC, Inc, Sumter, South Carolina, USA.

Abstract

BACKGROUND: The landscape of infectious diseases research by interprofessional teams continues to change in both scope and engagement. Limited information exists regarding publication metrics and factors associated with publication of abstracts presented at professional infectious diseases meetings. METHODS: This was a retrospective, observational study evaluating abstracts presented at IDWeek in…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.